Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/18/2025

Management of Microcytic Anemia

Initial Diagnostic Evaluation

  • The American Gastroenterological Association recommends that serum ferritin is the most specific test for iron deficiency in the absence of inflammation, with levels <30 μg/L indicating iron deficiency 1
  • In the presence of inflammation, serum ferritin up to 100 μg/L may still be consistent with iron deficiency, according to the Journal of Crohn's and Colitis 4
  • A low MCV with elevated red cell distribution width (RDW >14.0%) suggests iron deficiency anemia, as stated by Praxis Medical Insights 3
  • The European Crohn’s and Colitis Organisation suggests that a low MCV with normal RDW (≤14.0%) suggests thalassemia trait 3

Differential Diagnosis

  • Anemia of chronic disease is characterized by low iron, low TIBC, and normal/high ferritin, as described by Praxis Medical Insights 2, 3
  • Genetic disorders of iron metabolism or heme synthesis, such as SLC11A2 defects, should be considered in patients with unexplained microcytic anemia with increased TSAT, according to Blood 5, 6

Investigation of Underlying Causes

  • The American College of Gastroenterology recommends investigating for gastrointestinal blood loss as it is the most common cause of iron deficiency anemia in men and post-menopausal women 1
  • Other causes to consider include menstrual blood loss in pre-menopausal women, malabsorption, poor dietary intake, previous gastrectomy, and NSAID use, as stated by Gut 1

Treatment Approach

  • The American College of Physicians recommends first-line treatment with oral iron supplementation for at least three months after correction of anemia, with ferrous sulfate 200 mg three times daily as standard dosing 3
  • Adding ascorbic acid can enhance iron absorption, according to Praxis Medical Insights 2, 3
  • For patients who fail to respond to oral iron therapy, consider intravenous (IV) iron if there is malabsorption, as suggested by Praxis Medical Insights 3

Monitoring and Follow-up

  • The American Society of Hematology recommends monitoring hemoglobin concentration and red cell indices at three-month intervals for one year and then after a further year 3
  • In patients receiving iron therapy for genetic disorders, monitor iron status to detect toxic iron loading early, as stated by Blood 5

Special Considerations

  • Genetic testing should be considered in patients with refractory microcytic anemia despite adequate iron supplementation, according to Praxis Medical Insights 3
  • Family screening may be recommended for patients diagnosed with genetic disorders affecting iron metabolism, as suggested by Blood and Praxis Medical Insights 3, 5